Philly pharmacy sues drug wholesaler for making false accusations of overselling controlled substances
The owner of a pharmacy in Philadelphia says that a drug supplier damaged the neighborhood store’s reputation after making a false accusation that it over-purchased and sold a controlled substance, according to a libel suit filed at the Philadelphia Court of Common Pleas.
Uchenna Umeweni, owner of Bridge & Platt Family Pharmacy on Frankford Ave. in Philadelphia, seeks damages in excess of $250,000 from wholesaler Independent Pharmacy Cooperative and the Pharma Compliance Group, an auditing company.
According to the complaint, the Bridge & Platt Family Pharmacy had been purchasing the antidepressant drug Wellbutrin from the Independent Pharmacy Cooperative for more than 12 years. In June 2014, Umeweni learned that the wholesaler had started to acquire controlled medications for distribution and filled out a form to order the drugs for resale at the store.
After sending the electronic order, Umeweni contacted a representative a few days later, who told the plaintiff that an auditor would be arriving to inspect the premises. On June 26, an agent from the Pharma Compliance Group arrived at the pharmacy and accused Umeweni of overstocking and overselling Wellbutrin, calling it a class 2 controlled substance.
Umeweni informed the agent, Tony Scheller, a co-defendant, that Wellbutrin is not a controlled substance and that all of the orders have been documented by prescribing physicians at the nearby mental health facility. Following the inspection, Umeweni called the representative from the Independent Pharmacy Cooperative, co-defendent Brian Rucker, and protested the audit.
According to the complaint, Rucker accused Umeweni of changing his pharmacy name from Girard Pharmacy to Bridge & Platt Family Pharmacy and linked the store to recent drug bust on Girard Avenue. Rucker allegedly told the plaintiff that he is lucky the defendant did not catch him selling Wellbutrin on the street because he would have closed down the store and put him in jail.
The claim says the Scheller filed a derogatory and false report that has harmed Umeweni financially and give him a poor reputation. According to the complaint, the report has made it more difficult for him to purchase controlled substances from other suppliers.
The plaintiff is represented by attorney Christian Nduka in Philadelphia.
http://www.pharmacompliancegroup.com/
Our Commitment to You
Manufacturers, distributors, pharmacies, and healthcare practitioners share a mission and a responsibility to continuously monitor, protect and enhance the safety of the legitimate pharmaceutical supply chain, and to combat increasingly sophisticated criminals who attempt to breach the security of the closed system of distribution. Firms that distribute controlled substances must establish comprehensive internal policies and guidelines to prevent the diversion of controlled substances. Fines and other penalties levied against DEA registrants that have not been in compliance with the CSA and DEA requirements have increased dramatically.
The Pharma Compliance Group is committed to providing the pharmaceutical industry with the expertise needed to operate in total compliance of federal and state controlled substance regulations. We are a full service company dedicated to assisting our clients avoid costly regulatory and legal difficulties.
Filed under: General Problems
The Pharma Compliance Group — making big bucks off the drug war, every single day. I guess we should thank the DEA for helping to employ so many people.